Toshiba America Medical Systems will present ongoing developments in coincidence imaging at next month’s Society of Nuclear Medicine conference in Toronto. The Tustin, CA-based company will feature its Toshiba E.Cam attenuation correction and
Toshiba America Medical Systems will present ongoing developments in coincidence imaging at next months Society of Nuclear Medicine conference in Toronto. The Tustin, CA-based company will feature its Toshiba E.Cam attenuation correction and coincidence imaging programs, as well as coincidence images displayed on its UltraSPARC workstations.
Toshiba last year won rights to Siemens Medical Systems E.Cam, a variable-angle, dual-head gamma camera. Since the agreement, the company has emphasized its Sun Microsystems workstation technology as a point of distinction between its camera and the Siemens offering (SCAN 4/2/97). Adding E.Cam to its product line has enabled the company to participate in the cardiac and coincidence detection segments, said Dan Davis, manager of the companys nuclear medicine business unit. Toshiba will display E.Cam at the SNM conference, as well as its single-head GCA 7100A, which also is based on the Ultra computer.
At last years Radiological Society of North America meeting, Toshiba and Siemens announced the extension of their OEM agreement, taking the deal beyond basic E.Cam sales and adding development of coincidence detection imaging to the partnership. This year, Toshiba plans to offer coincidence-ready E.Cams to customers by mid-summer, with a coincidence software package to follow in the first quarter of 1999. The package will use iterative reconstruction algorithms to process images on Ultra workstations.
In other areas of its SNM booth, Toshiba will present work-in-progress techniques in image fusion, merging nuclear medicine images with CT and MRI scans to create one image that incorporates anatomical and physiological data. The company will also display teleradiology software and programs that translate data from cameras manufactured by other companies to Toshiba computers.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.